skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines Pneumococcal polysaccharide conjugate vaccine (21-valent)Question & answer

Pneumococcal polysaccharide conjugate vaccine (21-valent) · Medicine question

Who can receive this vaccine under its UK licence?

iatroX medicinesPublished 18 August 2026Reviewed 18 August 2026

The answer

Answer

Adults can receive it. Children and adolescents from age 2 may receive it after completing primary paediatric pneumococcal vaccination.

Sources for this answer

CAPVAXIVE solution for injection in pre-filled syringeemc · SmPC Current selected SmPC · Version 1

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Pneumococcal polysaccharide conjugate vaccine (21-valent)

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Pneumococcal polysaccharide conjugate vaccine (21-valent) guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

More questions about Pneumococcal polysaccharide conjugate vaccine (21-valent)

Can it be given with a flu vaccine?Does immunosuppression affect it?Should vaccination be delayed during illness?